CTXR vs XOM · rev $7.1M vs P/E 24, rev $201.16B
Citius Pharmaceuticals Inc (CTXR) versus Exxon Mobil Corp (XOM) — a side-by-side from cached financials, not a winner call.
Citius Pharmaceuticals Inc (CTXR) is a biotechnology company listed on US.
Exxon Mobil Corp (XOM) is a oil & gas integrated company listed on NYSE. It is led by Darren Woods.
Latest reported CTXR revenue for 2026-06-30 was $7.1M. Net income was -$49.4M. Revenue was up 26.6% from 2026-03-31 to 2026-06-30. CTXR currently screens at market cap $13.4M.
Latest reported XOM revenue for 2026-06-30 was $201.16B. Net income was $18.71B. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
CTXR currently screens at market cap $13.4M. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
Not investment advice. Open the CTXR and XOM stock pages for the full models.
Not investment advice.